RSS Feed
Hemispherx's Ampligen Dealt FDA Blow
Hemispherx BioPharma said the Food and Drug Administration refused to approve the experimental drug Ampligen for use in patients with chronic fatigue syndrome.
09:58AM 12/02/09
FDA Approves Two New Drugs: BioBuzz
Dyax and Merck/Santarus get FDA approvals. The U.S. Food and Drug Administration approved two drugs Tuesday night -- a prescription drug for a rare, genetic disorder and an over-the-counter treatment for heartburn.
07:30AM 12/02/09
Protalix-Pfizer Tag Team Against Genzyme: BioBuzz
New partnership for Gaucher's drug takes aim at Genzyme.
10:09AM 12/01/09
Research Firm Lays Out Surprise Bio Events for 2010: BioBuzz
Stocks will move if any of these unexpected events come true.
11:16AM 11/30/09
Biotech Calendar: Key Dates for December
A calendar of important, potentially stock-moving biotech events for December.
09:56AM 11/30/09
Biotech Stock Mailbag: Targacept
Targacept's depression drug TC-5214 makes it a great candidate to land a lucrative partnership from Big Pharma.
06:00AM 11/27/09
Cel-Sci's History of Disappearing Drugs: BioBuzz
Will Cel-Sci's flu drug last longer than its other fly-by-night projects?
09:20AM 11/24/09
BioCryst Bull Blames Conspiracy for Stock's Fall: BioBuzz
Hedge funds, Wall Street, SEC and FDA out to hurt maker of flu drug, newsletter writer claims.
06:45AM 11/24/09
Poniard Finds Cash to Keep Lights On: BioBuzz
Poniard faces a cash-crunch situation after a failed drug test last week.
12:59PM 11/23/09
Cel-Sci Chairman Sells Stock, Despite Sweetheart Loan Deal: BioBuzz
Shareholders are on the hook for a generous loan repayment to Cel-Sci's founder.
10:14AM 11/23/09
Connect with TheStreet